M Furuta Selected Research

M Furuta Research Topics

7	Neoplasms (Cancer) 12/2015 - 03/2000
5	Type 2 Diabetes Mellitus (MODY) 08/2012 - 06/2000
3	Deglutition Disorders (Dysphagia) 12/2017 - 04/2014
3	Obesity 05/2001 - 10/2000
3	Insulin Resistance 02/2001 - 06/2000
2	Malnutrition (Nutritional Deficiencies) 01/2016 - 04/2014
2	Hypertension (High Blood Pressure) 11/2010 - 12/2000
2	Hyperthermia 08/2001 - 01/2001
1	Mycoses (Diseases, Fungus) 10/2017
1	Dysbiosis 10/2017
1	Frailty 10/2017
1	Neoplasm Metastasis (Metastasis) 08/2015
1	Hemorrhage 08/2015
1	Melanoma (Melanoma, Malignant) 11/2006
1	Ventricular Dysfunction 08/2006
1	Cicatrix (Scar) 06/2006
1	Heart Failure 06/2006
1	Astrocytoma (Pilocytic Astrocytoma) 03/2006
1	Carcinogenesis 06/2004
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2001
1	Hypoglycemia (Reactive Hypoglycemia) 07/2001
1	Hyperplasia 07/2001
1	Body Weight (Weight, Body) 12/2000
1	Weight Loss (Weight Reduction) 12/2000
1	Hyperglycemia 12/2000
1	Pain (Aches) 12/2000
1	Leprosy (Hansen's Disease) 09/2000
1	Hearing Loss (Hearing Impairment) 07/2000
1	Meniere Disease (Menieres Disease) 07/2000
1	Vertigo (Positional Vertigo) 07/2000
1	Pathologic Nystagmus 07/2000
1	Necrosis 06/2000
1	Glucose Intolerance 06/2000
1	Macular Edema 05/2000
1	Retinal Vein Occlusion 05/2000
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2000
1	Chronic Hepatitis C 01/2000
1	Porphyria Cutanea Tarda 01/2000

4	Glucose (Dextrose)FDA LinkGeneric 07/2001 - 10/2000
3	Insulin (Novolin)FDA Link 05/2001 - 10/2000
2	Proteins (Proteins, Gene)FDA Link 03/2006 - 06/2004
2	alpha-MSHIBA 05/2001 - 10/2000
2	LeptinIBA 05/2001 - 10/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2000 - 06/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Untranslated Regions (Untranslated Region)IBA 12/2015
1	Explosive Agents (Explosives)IBA 12/2015
1	6H,8H- 3,4- dihydropyrimido(4,5- c)(1,2)oxazin- 7- oneIBA 08/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 08/2012
1	Nonesterified Fatty Acids (NEFA)IBA 08/2012
1	cyclopropapyrroloindoleIBA 11/2010
1	Tumor Biomarkers (Tumor Markers)IBA 03/2006
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 10/2001
1	Iridium-192IBA 08/2001
1	Glucagon (Glukagon)FDA Link 07/2001
1	Proprotein Convertase 2IBA 07/2001
1	Agouti-Related ProteinIBA 05/2001
1	Peptides (Polypeptides)IBA 03/2001
1	Islet Amyloid PolypeptideIBA 03/2001
1	Amyloid (Amyloid Fibrils)IBA 03/2001
1	pro-islet amyloid polypeptideIBA 03/2001
1	Indicators and Reagents (Reagents)IBA 02/2001
1	Morphine (MS Contin)FDA LinkGeneric 12/2000
1	Antihypertensive Agents (Antihypertensives)IBA 12/2000
1	Blood Glucose (Blood Sugar)IBA 12/2000
1	Melanocyte-Stimulating Hormones (MSH)IBA 10/2000
1	ParaffinIBA 09/2000
1	Glycerol (Glycerine)FDA LinkGeneric 07/2000
1	Troglitazone (Rezulin)FDA Link 06/2000
1	InterferonsIBA 01/2000
1	RNA (Ribonucleic Acid)IBA 01/2000

3	Home Nursing (Nursing, Home) 12/2017 - 01/2016
2	Radiotherapy 11/2006 - 03/2000
2	Therapeutics 06/2004 - 12/2000
2	Brachytherapy 08/2001 - 01/2001
1	Activities of Daily Living (ADL) 12/2017
1	Long-Term Care 04/2014
1	Transplantation 08/2006
1	Cell Transplantation 06/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 06/2006
1	Catheters 08/2001
1	Aftercare (After-Treatment) 02/2001
1	Caloric Restriction 12/2000
1	Infusion Pumps (Infusion Pump) 12/2000
1	Vitrectomy 05/2000
1	Radiation Dosimeters 03/2000